Funding news
Sketchy logo

Sketchy Raises $3.0M Series

Recently funded · $3.0M Series aEducationUS

Get the full Sketchy company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Sketchy, the visual learning platform, has secured $3.0 million in new investment capital from investors. This funding round will support the company's ongoing efforts to enhance its revolutionary approach to education, which transforms complex subjects into memorable visual stories.

The platform, founded in 2013 by four medical students, leverages a combination of art, science, and technology to help students effortlessly learn and recall information, leading to higher exam scores. Sketchy is currently utilized by students at every medical school in America, with 90% of its medical student users reporting higher test scores. Furthermore, 94% of users indicate that studying with Sketchy saves them time, and 78% report improved recall speed. The company states that 400,000 students have become doctors thanks to its methodology.

This capital infusion will be deployed to accelerate product development, expand Sketchy's content library across various subjects, and scale its operational capabilities to meet increasing demand. The investment underscores continued confidence in Sketchy's innovative educational model and its proven impact on student success. Sketchy is a portfolio company of TCG (The Chernin Group) and Reach Capital, aligning with their focus on innovative and engaging brands.

Looking ahead, Sketchy plans to use these funds to further its mission of making learning more accessible and effective for students worldwide. The company aims to broaden its reach and continue developing tools that empower learners to master challenging material through engaging visual narratives.

Other United States companies recently funded

View all

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Alitheon logo

Alitheon

United States

$8.0M
2
Tavo Biotherapeutics logo

Tavo Biotherapeutics

$17.0M
3
Adaptive Innovations Corp logo

Adaptive Innovations Corp

United States

$50.0M
4
Novellia logo

Novellia

United States

$18.0M
5
GenerativeX logo

GenerativeX

United States

$650.0M